Source: News & Observer

Biotechnology company Grifols has a large presence in the Triangle area of North Carolina. Its Clayton facility may play a large role in uncovering a useful treatment for the coronavirus.

According to the News & Observer, Grifols is entering the first stages of a clinical trial at its Clayton facility. Grifols is pairing with the U.S. Biomedical Advanced Research Development Authority (BARDA) and the Food and Drug Administration (FDA) to harvest plasma, the N&O reports. 

Testing the plasma could help researchers determine if antibodies in recovering COVID-19 patients could be used to treat coronavirus. Grifols believes that coronavirus-fighting antibodies could be injected into patients unable to fight coronavirus themselves. 

Grifols is the largest private employer in Johnston County, with more than a thousand employees at their Clayton facilities.

Read more about the prospects of a COVID-19 treatment from Grifols from the News & Observer.